Literature DB >> 5635892

Correspondence: the biotransformation of halothane.

A Stier.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1968        PMID： 5635892     DOI： 10.1097/00000542-196803000-00033

Source DB:  PubMed          Journal:  Anesthesiology        ISSN： 0003-3022            Impact factor:   7.892


× No keyword cloud information.
  6 in total

1.  In vivo and in vitro studies on irreversible binding of halothane metabolites to proteins.

Authors:  V Hempel; H Remmer
Journal:  Experientia       Date:  1975-06-15

Review 2.  Halothane hepatitis--fact or fallacy?

Authors:  B R Simpson; L Strunin; B Walton
Journal:  Proc R Soc Med       Date:  1973-01

3.  Drug metabolising activity of freshly isolated human hepatocytes.

Authors:  L B Tee; T Seddon; A R Boobis; D S Davies
Journal:  Br J Clin Pharmacol       Date:  1985-03       Impact factor: 4.335

4.  Metabolic activation of halothane and its covalent binding to liver endoplasmic proteins in vitro.

Authors:  H Uehleke; K H Hellmer; S Tabarelli-Poplawski
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1973       Impact factor: 3.000

5.  Modification of liver microsomal lipids by halothane metabolites; a multi nuclear NMR spectroscopic study.

Authors:  R Müller; A Stier
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-12       Impact factor: 3.000

Review 6.  Biochemical studies on the metabolic activation of halogenated alkanes.

Authors:  K H Cheeseman; E F Albano; A Tomasi; T F Slater
Journal:  Environ Health Perspect       Date:  1985-12       Impact factor: 9.031
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.